Latvia faces flu vaccine shortages after delivery delays

Latvia faces flu vaccine shortages after delivery delays
First reported by bnn-news.com

Latvian medical practices are currently managing significant influenza vaccine shortages as only half of the 150,000 doses ordered for the current season have arrived in the country. Production and logistics disruptions affecting the broader European market have hindered the distribution process, forcing family doctors to implement waiting lists for patients seeking immunization.

Impact on high-risk patient groups

The national vaccination strategy prioritizes three specific groups: children, individuals living with chronic illnesses, and seniors aged 60 and older. According to Līga Kozlovska, a family doctor and board member of the Latvian Rural Family Doctors Association, the supply constraints are directly affecting these vulnerable populations. In one instance, a practice that requested 300 doses for elderly patients received only 100, leaving the remainder of the order pending. These delays have created challenges for healthcare providers attempting to manage patient expectations and ensure that those at the highest risk receive protection before the peak of the influenza season.

Monitoring current influenza activity

While vaccine availability remains limited, the Centre for Disease Prevention and Control (SPKC) reports that influenza activity is rising across the country. During week 44, the clinical diagnosis rate for influenza reached 15.0 cases per 100,000 inhabitants, up from 9.2 cases the previous week. This trend is most pronounced among children aged 5 to 14, where the incidence rate climbed to 57.7 cases per 100,000 inhabitants. Laboratory surveillance confirms the presence of the A(H1)pdm virus subtype, which accounted for all identified influenza samples during the monitoring period. Despite these increases, overall influenza activity remains below the official epidemic threshold, and current incidence rates are consistent with historical averages for this time of year over the past five seasons.

Broader respiratory health trends

Health authorities are also tracking other respiratory illnesses, including pneumonia and SARS-CoV-2. Pneumonia incidence saw a marginal rise, moving from 8.0 to 11.0 cases per 100,000 inhabitants. Meanwhile, the proportion of positive test samples for SARS-CoV-2 increased to 3.4% in week 44, up from 0.5% the prior week. Conversely, hospitalizations for severe acute respiratory infections (SARI) have declined, with 110 patients admitted to monitoring hospitals compared to 165 the previous week. The country has recorded its first death associated with a confirmed influenza infection for the current monitoring season.

Expectations for supply stabilization

The healthcare sector anticipates a shift in vaccine availability following the 13th of November. A major nationwide delivery is scheduled for after this date, which is expected to alleviate the current pressure on family doctor practices and allow for the fulfillment of outstanding orders. Until these shipments arrive, medical professionals continue to manage existing stocks while monitoring the evolving respiratory health landscape.